{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:11:05Z","timestamp":1781115065877,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0014416","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000}}],"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370016"],"award-info":[{"award-number":["82370016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2023YFC2506000"],"award-info":[{"award-number":["2023YFC2506000"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2301800"],"award-info":[{"award-number":["2021YFC2301800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900572"],"award-info":[{"award-number":["81900572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe fever with thrombocytopenia syndrome (SFTS) carries high short-term mortality and lacks approved antiviral therapy, highlighting the need for admission risk tools grounded in upstream host immune pathobiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Public single-cell RNA sequencing (scRNA-seq) data (GSE175499) from 15 SFTS patients (4 non-survivors, 11 survivors) and 4 healthy controls were reanalyzed to map cell\u2013cell communication and identify monocyte subsets and pathways. Findings were validated by bulk RNA sequencing and flow cytometry. A multicenter clinical cohort (n\u2009=\u2009150, 132 survivors and 18 non-survivors) measured admission sCD163 using enzyme-linked immunosorbent assay (ELISA) and assessed 30-day mortality using area under the curve (AUC), Kaplan\u2013Meier, and Cox models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Single-cell analysis identified expansion of CD163\u2009\u207a\u2009intermediate monocytes in SFTS, along with antiviral and complement activation programs in non-survivors. Communication analysis prioritized thrombospondin (THBS) signaling with the dominant sender shifting from CD163\u2009\u207a\u2009intermediate (survivors) to CD163\u2009\u207a\u2009classical monocytes (non-survivors). Flow cytometry confirmed increased CD163\u2009\u207a\u2009monocytes in SFTS. At admission, sCD163 independently predicted 30-day mortality (optimal threshold\u2009=\u20091.17 \u00b5g\/mL, AUC 0.80). A two-marker model combining sCD163 with blood urea nitrogen (BUN) improved discrimination (AUC 0.87), yielded stepwise separation across three risk tiers (Score 0, 1, and 2) and replicated externally (AUC 0.73 and 0.83). Elevated sCD163 was consistently associated with higher mortality across sex and age subgroups. However, further subgroup analyses within the three-tier risk score were limited by small sample sizes and should be considered exploratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified and orthogonally validated CD163\u2009\u207a\u2009monocyte programs linked to outcomes, establishing admission serum sCD163 as a biomarker. An admission two-marker score (sCD163 and BUN) provides a simple three-tier admission score that rapidly stratifies 30-day mortality risk and guides intensified monitoring and timely supportive care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0014416","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:46:31Z","timestamp":1780508791000},"page":"e0014416","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD163\u207a monocytes and soluble CD163 as prognostic indicators in severe fever with thrombocytopenia syndrome: An integrative analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-5956","authenticated-orcid":true,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"10","key":"pntd.0014416.ref001","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3201\/eid2110.141928","article-title":"Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome, South Korea, 2013","volume":"21","author":"J Shin","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"pntd.0014416.ref002","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan","volume":"209","author":"T Takahashi","year":"2014","journal-title":"J Infect Dis"},{"key":"pntd.0014416.ref003","first-page":"101133","article-title":"Global epidemiology of severe fever with thrombocytopenia syndrome virus in human and animals: a systematic review and meta-analysis","volume":"48","author":"H Cui","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"pntd.0014416.ref004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/v16010128","article-title":"Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development","volume":"16","author":"D Kim","year":"2024","journal-title":"Viruses"},{"issue":"8","key":"pntd.0014416.ref005","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cmi.2025.02.004","article-title":"Development and validation of a novel mortality risk stratification simplified scoring scale for severe fever with thrombocytopenia syndrome","volume":"31","author":"T Chen","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"pntd.0014416.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012068","article-title":"Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome","volume":"18","author":"S Zhang","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0014416.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013104","article-title":"Association between serum ferritin and mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study","volume":"19","author":"W Xiao","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014416.ref008","doi-asserted-by":"crossref","unstructured":"Peng W. Activated partial thromboplastin time predicts mortality in patients with severe fever with thrombocytopenia syndrome: A multicenter study in north China. 2024.","DOI":"10.1016\/j.heliyon.2024.e31289"},{"key":"pntd.0014416.ref009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2015.12.009","article-title":"Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS)","volume":"43","author":"C Peng","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"2","key":"pntd.0014416.ref010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gutjnl-2024-333308","article-title":"Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression","volume":"75","author":"X Liang","year":"2026","journal-title":"Gut"},{"issue":"4","key":"pntd.0014416.ref011","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2008-07-167064","article-title":"The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria","volume":"113","author":"BO Fabriek","year":"2009","journal-title":"Blood"},{"issue":"5","key":"pntd.0014416.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019968","article-title":"Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals","volume":"6","author":"E Tippett","year":"2011","journal-title":"PLoS One"},{"key":"pntd.0014416.ref013","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virusres.2018.05.021","article-title":"Expression of CD206 and CD163 on intermediate CD14++CD16+ monocytes are increased in hemorrhagic fever with renal syndrome and are correlated with disease severity","volume":"253","author":"X Li","year":"2018","journal-title":"Virus Res"},{"issue":"20","key":"pntd.0014416.ref014","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/cells13201679","article-title":"The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology","volume":"13","author":"A Plevriti","year":"2024","journal-title":"Cells"},{"issue":"8","key":"pntd.0014416.ref015","doi-asserted-by":"crossref","first-page":"110039","DOI":"10.1016\/j.celrep.2021.110039","article-title":"Single-cell landscape of peripheral immune responses to fatal SFTS","volume":"37","author":"H Li","year":"2021","journal-title":"Cell Rep"},{"issue":"8","key":"pntd.0014416.ref016","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175241","article-title":"Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liver","volume":"135","author":"JD Sanchez Vasquez","year":"2025","journal-title":"J Clin Invest"},{"issue":"8","key":"pntd.0014416.ref017","doi-asserted-by":"crossref","first-page":"110039","DOI":"10.1016\/j.celrep.2021.110039","article-title":"Single-cell landscape of peripheral immune responses to fatal SFTS","volume":"37","author":"H Li","year":"2021","journal-title":"Cell Rep"},{"issue":"15","key":"pntd.0014416.ref018","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"AK McElroy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pntd.0014416.ref019","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201343RR","article-title":"CD8+ T cells mediate antiviral response in severe fever with thrombocytopenia syndrome","volume":"37","author":"L Zong","year":"2023","journal-title":"FASEB J"},{"issue":"9","key":"pntd.0014416.ref020","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.4049\/jimmunol.153.9.4219","article-title":"Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes","volume":"153","author":"PJ Mansfield","year":"1994","journal-title":"J Immunol"},{"issue":"7","key":"pntd.0014416.ref021","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1582-4934.2009.00799.x","article-title":"Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance","volume":"14","author":"T Kirsch","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"6","key":"pntd.0014416.ref022","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.177.6.3534","article-title":"Thrombospondin\/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation","volume":"177","author":"P Grimbert","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"pntd.0014416.ref023","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.20030705","article-title":"Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation","volume":"198","author":"V Doyen","year":"2003","journal-title":"J Exp Med"},{"issue":"2","key":"pntd.0014416.ref024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"F Venet","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"pntd.0014416.ref025","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"RS Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"pntd.0014416.ref026","article-title":"Effect of fasting plasma glucose level in severe fever and thrombocytopenia syndrome patients without diabetes","volume":"18","author":"J Pan","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0014416.ref027","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.3892\/mmr.2017.6393","article-title":"Clinical significance of sCD163 and its possible role in asthma (Review)","volume":"15","author":"Y Zhi","year":"2017","journal-title":"Mol Med Rep"},{"issue":"5","key":"pntd.0014416.ref028","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2007.05.014","article-title":"Soluble CD163 from activated macrophages predicts mortality in acute liver failure","volume":"47","author":"HJ M\u00f8ller","year":"2007","journal-title":"J Hepatol"},{"issue":"4","key":"pntd.0014416.ref029","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jhep.2015.11.021","article-title":"Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)","volume":"64","author":"H Gr\u00f8nb\u00e6k","year":"2016","journal-title":"J Hepatol"},{"issue":"7","key":"pntd.0014416.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038400","article-title":"Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study","volume":"7","author":"L Feng","year":"2012","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0014416","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:54:30Z","timestamp":1781114070000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014416"}},"subtitle":[],"editor":[{"given":"Richard A.","family":"Bowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014416","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}